Heo et al. developed direct CXCR4-targeted 64Cu-CuNCs-FC131 with specific binding that enabled a high specific activity in triple-negative breast cancer (TNBC) imaging patient-derived xenograft mouse models and human TNBC tissues [68]. The gene discussed is CXCR4; the disease is triple-negative breast carcinoma.